Inter Parfums (IPAR) director boosts stake via 1,500-share option exercise

Rhea-AI Filing Summary

Inter Parfums Inc. director Robert Bensoussan-Torres reported exercising stock options and increasing his direct shareholdings. On January 22, 2026, he exercised four “option-right to buy” awards for a total of 1,500 shares of common stock at an exercise price of $62.18 per share, bringing his directly held common stock to 12,500 shares. He also continues to hold multiple option-right-to-buy awards for 300 shares each at exercise prices including $97.84, $130.6 and $84.64, with expiration dates running from 2028 to 2031.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BENSOUSSAN TORRES ROBERT

(Last) (First) (Middle)

VICTOR PALACE

31 AVENUE DE GRANDE

(Street)

BRETAGNE O9 98000

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTERPARFUMS INC [ IPAR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								11,000	D
Common Stock	01/22/2026		M		1,500	A	$62.18	12,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option-right to buy	$62.18	01/22/2026		M			375	02/01/2022	01/31/2026	Common Stock	375	$0	0	D
Option-right to buy	$62.18	01/22/2026		M			375	02/01/2023	01/31/2026	Common Stock	375	$0	0	D
Option-right to buy	$62.18	01/22/2026		M			375	02/01/2024	01/31/2026	Common Stock	375	$0	0	D
Option-right to buy	$62.18	01/22/2026		M			375	02/01/2025	01/31/2026	Common Stock	375	$0	0	D
Option-right to buy	$97.84							12/31/2023	12/30/2028	Common Stock	300		300	D
Option-right to buy	$97.84							12/31/2024	12/30/2028	Common Stock	300		300	D
Option-right to buy	$97.84							12/31/2025	12/30/2028	Common Stock	300		300	D
Option-right to buy	$97.84							12/31/2026	12/30/2028	Common Stock	300		300	D
Option-right to buy	$97.84							12/31/2027	12/30/2028	Common Stock	300		300	D
Option-right to buy	$147.71							12/29/2024	12/28/2029	Common Stock	300		300	D
Option-right to buy	$147.71							12/29/2025	12/28/2029	Common Stock	300		300	D
Option-right to buy	$147.71							12/29/2026	12/28/2029	Common Stock	300		300	D
Option-right to buy	$147.71							12/29/2027	12/28/2029	Common Stock	300		300	D
Option-right to buy	$147.71							12/29/2028	12/28/2029	Common Stock	300		300	D
Option-right to buy	$130.6							12/31/2025	12/30/2030	Common Stock	300		300	D
Option-right to buy	$130.6							12/31/2026	12/30/2030	Common Stock	300		300	D
Option-right to buy	$130.6							12/31/2027	12/30/2030	Common Stock	300		300	D
Option-right to buy	$130.6							12/31/2028	12/30/2030	Common Stock	300		300	D
Option-right to buy	$130.6							12/31/2029	12/30/2030	Common Stock	300		300	D
Option-right to buy	$84.64							12/31/2026	12/30/2031	Common Stock	300		300	D
Option-right to buy	$84.64							12/31/2027	12/30/2031	Common Stock	300		300	D
Option-right to buy	$84.64							12/31/2028	12/30/2031	Common Stock	300		300	D
Option-right to buy	$84.64							12/31/2029	12/30/2031	Common Stock	300		300	D
Option-right to buy	$84.64							12/31/2030	12/30/2031	Common Stock	300		300	D

Explanation of Responses:

	/s/ Robert Bensoussan-Torres by Joseph A. Caccamo as attorney-in-fact	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IPAR director Robert Bensoussan-Torres report?

Robert Bensoussan-Torres reported exercising stock options in Inter Parfums Inc. and acquiring 1,500 shares of common stock on January 22, 2026 through option exercises coded as transaction type M (option exercise).

How many Inter Parfums (IPAR) shares does the director hold after this Form 4?

Following the reported transactions, Robert Bensoussan-Torres beneficially owns 12,500 shares of Inter Parfums common stock in direct ownership, as shown in Table I of the filing.

At what price were the IPAR options exercised in this Form 4?

The options converted into common stock were exercised at an exercise price of $62.18 per share, resulting in the acquisition of 1,500 shares of Inter Parfums common stock on January 22, 2026.

What derivative holdings does the IPAR director still have after the option exercises?

After exercising some awards, the director continues to hold several option-right to buy positions for 300 shares of common stock each at exercise prices including $97.84, $130.6 and $84.64, with expiration dates ranging from December 30, 2028 to December 30, 2031.

Is the Inter Parfums (IPAR) Form 4 transaction a purchase or sale of shares?

The Form 4 shows option exercises coded M in Table II that resulted in the acquisition of 1,500 shares of common stock reported as A in Table I, rather than an open-market sale.

What is the reporting person’s role at Inter Parfums Inc. (IPAR)?

The reporting person, Robert Bensoussan-Torres, is listed as a director of Inter Parfums Inc. on this Form 4 and is filing as an individual reporting person.